Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
TG Therapeutics, Inc. is a fully integrated, commercial stage biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its products include Ublituximab IV (anti-CD20 mAb), Ublituximab IV Simplified Dosing Schedule, Ublituximab Subcutaneous (anti-CD20 mAb), and Azer-cel. It is engaged in late-stage clinical development of BRIUMVI. BRIUMVI is an anti-CD20 monoclonal antibody that can be administered to adults with relapsing forms of multiple sclerosis (RMS) in a one-hour infusion every 24 weeks, following the starting dose. It is used for treatment of adults with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. The Company is also engaged in ULTIMATE I & II Trials Evaluating Single Agent Ublituximab in RMS. Its ENHANCE Phase 3b Trial is an ongoing, multi-center, open-label study designed to evaluate alternative dosing regimens for BRIUMVI in patients with RMS.
Find out what a historical investment in TG Therapeutics Inc would be worth today using our TGTX stock calculator.
Buying TGTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in TG Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in TGTX
What is the ticker symbol of TG Therapeutics Inc?
The ticker symbol for TG Therapeutics Inc is TGTX.
How much is one share of TGTX?
One share of TGTX is valued at $63.34 as of 22 November 2026.
What is the market capitalisation of TG Therapeutics Inc TGTX?
As of 22 November 2026 TG Therapeutics Inc has a market cap of $9.57B.
What is the P/E ratio of TGTX?
The Price to Earnings ratio of TGTX is 96.36.
What is the Earnings Per Share of TGTX?
The Earnings Per Share of TGTX is $0.67.
What is the 52-week high for TG Therapeutics Inc stock?
The TG Therapeutics Inc 52-week high stock price is $68.03.
What is the 52-week low for TG Therapeutics Inc stock?
The TG Therapeutics Inc 52-week low stock price is $26.76.
Can I buy TGTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TGTX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TGTX on Stake
Buy TGTX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of TGTX from only US$10 with fractional shares